A 35-year-old woman from a rural village in Odisha presents to the primary health centre with a 2-year history of progressive neck swelling and difficulty swallowing. On examination, she has a firm, diffuse, non-tender thyroid enlargement (Grade II goitre). She reports that her 8-year-old son has similar neck swelling and poor school performance. Urine iodine excretion is 45 µg/L (normal >100 µg/L). The village has no access to iodized salt. What is the most appropriate immediate public health intervention for this community?

## Iodine Deficiency Control Programme: Community-Level Management ### Clinical Context This patient and her son represent endemic iodine deficiency disorder (IDD) in an iodine-deficient region. The low urine iodine excretion (<100 µg/L) confirms inadequate iodine intake at the population level. ### Correct Approach: Universal Salt Iodization (USI) **Key Point:** The primary strategy of India's National Iodine Deficiency Disorder Control Programme is **Universal Salt Iodization (USI)**, not individual treatment. **High-Yield:** USI is the most cost-effective, sustainable public health intervention for IDD elimination: - Reaches entire population through existing salt supply chains - Prevents new cases in children (cretinism, stunting, intellectual disability) - Reverses mild-to-moderate goitre in adults over 12–18 months - Requires no individual compliance or follow-up ### Why USI is Superior to Other Approaches | Intervention | Mechanism | Limitation | |---|---|---| | **USI (Correct)** | Fortify all edible salt with KIO₃ (30 ppm) | Requires policy implementation, but sustainable | | Levothyroxine | Treats established hypothyroidism only | Does not prevent new cases; expensive; requires compliance | | Thyroidectomy | Removes goitre tissue | Invasive; does not address underlying deficiency; recurrence possible | | KI supplementation | Acute iodine repletion | Temporary; does not address population-level deficiency; poor compliance | ### Implementation Details **Key Point:** India's USI programme mandates: 1. Fortification of all edible salt (both household and industrial use) with potassium iodate (KIO₃) at 30 ppm 2. Monitoring of salt iodine content at production and retail levels 3. Public awareness campaigns 4. Periodic population surveys (urine iodine, TSH screening) **Clinical Pearl:** Goitre in this patient will regress gradually (over 12–24 months) once adequate iodine intake is restored via iodized salt. Her son's intellectual development can be protected by early intervention. **High-Yield:** The target urine iodine excretion for a population is >100 µg/L (median). This patient's 45 µg/L indicates severe deficiency. ### Monitoring & Evaluation After USI implementation: - Repeat urine iodine surveys at 12 and 24 months - Monitor TSH and thyroid function in school children - Track goitre prevalence reduction [cite:Park 26e Ch 11]